Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. G.A.P. (Geke) Hospers

Publicaties

Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study

Corrigendum to "Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry" [Eur. J. Cancer 212, 2024, 115056]

Development of a Decision Model to Estimate the Outcomes of Treatment Sequences in Advanced Melanoma

Exploring intratumoral budding in colorectal cancer using computational pathology: a biopsy- based evaluation

Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement

Impact of personalized response-directed surgery and adjuvant therapy on survival after neoadjuvant immunotherapy in stage III melanoma: Comparison of 3-year data from PRADO and OpACIN-neo

Intrapatient 16α-[18F]Fluoro-17β-Estradiol PET Heterogeneity as a Prognostic Factor for Endocrine Therapy Response and Survival in Patients with Estrogen Receptor-Positive Metastatic Breast Cancer.

Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry

Adjuvant treatment with anti-PD-1 in acral melanoma: A nationwide study

Adverse Events in Anti-PD-1-Treated Adjuvant and First-Line Advanced Melanoma Patients

Pers/media

‘Het mooie is dat je het microbioom kunt veranderen’

Darmflora beïnvloedt effectiviteit immunotherapie bij huidkanker

Effectiviteit darmflora beïnvloed immunotherapie bij huidkanker

Newly Approved PET Imaging Agent Solves Clinical Dilemmas in Breast Cancer Patients